What's Trending

On December 3, the U.S. Securities and Exchange Commission settled charges against biotherapeutics company Kiromic BioPharma, Inc., its...

Over the last five years, stockholder activism has undergone significant transformation, shaped by changing market conditions, regulatory...

In September, the U.S. Department of Justice updated its Evaluation of Corporate Compliance Programs (ECCP) guidance, which is the...

Beginning December 18, Schedules 13D and 13G must be filed using an XML-based language. Filers will have the option of (1) using a...

Institutional Shareholder Services (ISS) recently reported on trends in corporate political activity disclosures and related shareholder...

The U.S. Food and Drug Administration will focus on “Total Product Lifecycle Considerations for Generative AI-Enabled Devices” during its...

Last week global professional services firm Accenture published its fourth annual Destination Net Zero report, in which it examined the...

Last Thursday, proxy advisory firm Glass Lewis released its 2025 Proxy Voting Policy Guidelines 2025 U.S. Benchmark Policy Guidelines,...

The U.S. Patent and Trademark Office (USPTO) has implemented three new rules impacting practice before the Patent Trial and Appeal Board...

Important opportunity for investors in the defense innovation and dual-use technology sectors!  The Defense Advanced Research Projects...

The U.S. Department of Defense (DoD) is turning to commercial space companies to solve logistical challenges, prioritizing reentry...

Public companies can breathe a sigh of relief, at least for now, that the Securities and Exchange Commission's 14a-8 regulatory process...